Oryon Cell Therapies
OC
OR

Oryon Cell Therapies

Agent22Agent Readiness: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 41.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Website
InactiveBelmont, USA

About

Oryon Cell Therapies is a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders. The company has emerged from stealth and secured significant funding to advance its therapeutic programs.

Key facts

At-a-glance profile data

Website
oryontherapies.com
Headquarters
Belmont, Massachusetts, USA
Total funding
$21M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by Oryon Cell Therapies
DateRoundAmountLead investors
23 Mar 2026Series A$21M-
Add first review

Frequently asked

How much funding has Oryon Cell Therapies raised?

Oryon Cell Therapies has raised a total of $21M in funding. The most recent round on record is Series A.

What is Oryon Cell Therapies's current status?

Oryon Cell Therapies's current operating status is: Inactive.